Israel’s leading retail chain in the field of optics, Opticana, hosted the particular first ever Optometry Innovation Conference Optivision by Opticana . Israel is at the forefront of innovation in most fields, and the field of optics is no different. As Merav Chapni Raz, deputy CEO and store manager in Opticana stated, “Our new-world technologies have also penetrated the examination rooms associated with optometrists. Today, they can offer an expanded set of tests and in-depth diagnoses using innovative and ground-breaking equipment and products. These items allow us to offer customers a variety of never-before-seen solutions plus optical treatments that improve the quality of vision and the quality of life of the people who wear glasses. We constantly work to update and strengthen the importance of the optometrist in the particular new plus developing world, and at the same time allow our customers in order to benefit from a good expanded and innovative collection of assessments. ” Here are some of the particular Israeli startups that are helping us see a bright, clearer future (pun intended).


RevitalVision is a digital health startup along with ground-breaking therapeutic software that enhances the brain’s visual processing abilities in patients with various eye diseases and visible impairments when no other alternative treatment is available or effective.

As 500 million people worldwide suffer from poor or insufficient vision which cannot be further improved by surgery, optical correction, or even medication, RevitalVision developed an unique solution for eye care specialists to additional improve vision beyond the particular eyes plus beyond current practices. While the entire vision care industry focuses on correcting the anatomy associated with the eyes and bending lights, RevitalVision focuses solely on optimizing the brain’s visual processing.

RevitalVision is the only FDA-cleared product for children age 9+ and adults with amblyopia (lazy eye) and is proven effective in improving vision in multiple eye diseases plus vision impairments. It has also just been approved with regard to two new unique USA CPT reimbursement codes by the AMA for the treatment of amblyopia.

RevitalVision was founded inside 2019 simply by Yair Yahav (CEO), and Yogev Shamay (CTO). They are located in Modi’in, His home country of israel and have 10 employees. To date, the company has raised $3 million and is currently raising more capital to scale up, along with a primary focus upon the U. S market.


NovaSight will be a medical device company with a mission to prevent eyesight impairments among pediatric individuals using attention tracking-based technology in novel therapeutics, diagnostic, and preventive solutions. The CureSight™ amblyopia treatment system is designed in order to replace traditional eye patching. The treatment is carried out while the particular patient watches his or her favourite streamed content from the comfort of their home. For visual diagnostics, the company is usually developing the particular EyeSwift®PRO eyesight tracking-based vision diagnostic device that screens for multiple vision impairments within seconds and may be used by any trained individual. Specially designed regarding children, the EyeSwiftPRO requires minimal patient cooperation. NovaSight is furthermore in the process associated with developing TrackSight™, a software-as-a-service (SaaS) answer for myopia prevention plus visual wellness monitoring. TrackSight is designed for use by children on laptops and tablets for both educational and leisure purposes as well as adults at the workplace for objective eye fatigue and dry eye monitoring.

EyeSwift®PRO. Credit: NovaSight

NovaSight has been founded inside 2016 simply by Ran Yam (CEO) plus Prof. Dan Oz (CTO). They possess 22 employees and are located in Airport City. NovaSight’s management and scientific advisory board are composed of experienced executives, researchers, and key opinion leaders in the particular field of pediatric eyesight care.

CU Control Lenses by Opticana

In 2000, there were about 1 . 4 billion people in the world who suffered from myopia (nearsightedness). According to estimates, in 2050 this number is expected to reach four. 8 billion, which is definitely about 50% of the world’s population. Why is there an increase in myopia? What changed? The new globe has created the new reality and transformed the life habits associated with millions of people as we have transitioned to the digital age. This brand new digital lifestyle with exposure to screens, computers, smartphones plus televisions on a daily basis, results in changes within far vision and creates nearsightedness. Recent studies show that will several main factors can lead in order to myopia amongst children — excessive make use of displays, dim lighting, little period outside the classroom and reduced contact with daylight, a lack of sleeping hours and reading from a distance. But how does myopia affect our health and standard of living? It may be related to a variety of medical complications like retinal detachments, glaucoma, cataracts, and changes in the optic disc. Moreover, if it is not treated it can affect a decrease in the functioning of learning abilities, social and occupational difficulties plus challenges, and damage to the quality of existence. Using advanced technology, CU Control has established an efficient treatment intended for myopia plus prevention of vision deterioration in kids aged 6-16 using eyeglasses. Their lenses can slow down the rate of development of myopia and reduce the elongation of the eyeball. The particular CU Control lenses have got power reduction, starting from the particular center associated with the lens, where there is maximum power and prevention up to the edge from the lens. The reduction works circularly and in all directions of the lens. The particular circular prescription reduction technologies changes the particular positions of the focus points to match the curvature of the retina precisely. Thanks to this technology, the particular aesthetic result is also better, as well as the lenses are thinner and give a high-level aesthetic appearance. The treatment is safe, effective, and easy and comfortable for children.

CU Control Lenses. Credit score: Opticana

Opticana was founded in 1988 by Meir and Sarit Rassin and provides the most advanced optometry services in Israel. As innovation is one of the company’s core values, they are always keeping up to date with technological changes in Israel and abroad in order to stand in the front of progress.

CooperVision His home country of israel

CooperVision is committed to helping people around the world see much better every day. Through scientific and technological innovation, operational excellence, plus close working relationships along with eye care professionals, CooperVision has helped improve the vision associated with millions and become a trusted global leader in the particular contact lens business.

The company designs and manufactures highly specialized contact lenses to get the management of myopia and some other indications. As no two eyes plus no two people are the same, providing eyesight correction contact lenses should be no various. And so, CooperVision His home country of israel is dedicated to providing a better quality of lifestyle through vision correction solutions. CooperVision Israel’s expertise can be in producing contact lens for every case and to fit every need, whether Multifocal, Toric, Keratoconus & Irregular corneas, Therapeutic & Baby lenses, Cosmetic, Prosthetic, Scleral, GP lenses, or custom designed.

CooperVision Product. Credit: CooperVision

CooperVision Israel was developed with the Acquisition of Soflex in 2016 and it is located inside Northern Israel and has 120 employees in Israel. They launched the first FDA-approved product pertaining to myopia administration 4 years ago – MiSight 1-day disposable lenses and continue to contribute in order to the field of myopia management through professional support, accreditations, and more approved products.

Leave a Reply

Your email address will not be published. Required fields are marked *